Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.16B | 30.91B | 31.91B | 31.54B | 33.38B |
Gross Profit | 2.46B | 3.17B | 3.25B | 3.21B | 3.78B |
EBITDA | 825.00M | 1.54B | 1.48B | 1.47B | 2.46B |
Net Income | 167.00M | 587.00M | 630.00M | 627.00M | 1.19B |
Balance Sheet | |||||
Total Assets | 24.55B | 27.69B | 28.16B | 27.55B | 27.11B |
Cash, Cash Equivalents and Short-Term Investments | 7.03B | 11.18B | 10.71B | 10.68B | 9.27B |
Total Debt | 34.00M | 33.00M | 25.00M | 25.00M | 38.00M |
Total Liabilities | 10.99B | 14.04B | 14.81B | 15.01B | 15.45B |
Stockholders Equity | 13.56B | 13.65B | 13.36B | 12.54B | 11.52B |
Cash Flow | |||||
Free Cash Flow | -3.55B | 831.00M | 1.35B | 1.70B | 561.00M |
Operating Cash Flow | -3.15B | 1.82B | 2.14B | 2.43B | 1.10B |
Investing Cash Flow | -600.00M | -1.00B | -793.00M | -752.00M | -520.00M |
Financing Cash Flow | -402.00M | -351.00M | -297.00M | -267.00M | -250.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥107.91B | 14.94 | 2.39% | 4.84% | 62.58% | ||
77 Outperform | ¥81.45B | 16.90 | 5.53% | 6.09% | 21.09% | ||
75 Outperform | ¥163.81B | 18.34 | 5.05% | 0.57% | 26.93% | ||
73 Outperform | ¥55.71B | 13.52 | 5.79% | 9.19% | 45.78% | ||
71 Outperform | ¥49.60B | 8.91 | 3.44% | 0.18% | 14.61% | ||
60 Neutral | ¥13.51B | 78.55 | 2.66% | 0.66% | -65.05% | ||
58 Neutral | HK$13.99B | 4.55 | -2.78% | 5.71% | 2.20% | -57.37% |